E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/9/2011 in the Prospect News PIPE Daily.

Hansen Medical gets $30 million term loan with Oxford, Silicon Valley

Investors also get warrants for 660,793 shares, exercisable at $2.27

By Devika Patel

Knoxville, Tenn., Dec. 9 - Hansen Medical, Inc. negotiated a $30 million term loan with Oxford Finance LLC and Silicon Valley Bank on Dec. 8, according to an 8-K filed Friday with the Securities and Exchange Commission. Oxford Finance was the collateral agent and is investing $20 million. Silicon Valley will invest $10 million.

The loan accrues interest at 9.45%.

As part of the loan, the investors received seven-year warrants for 660,793 common shares, exercisable at $2.27. The strike price is a 6.97% discount to the Dec. 7 closing share price of $2.44.

Settlement is expected on Friday.

The Mountain View, Calif.-based company develops and manufactures robotics designed to position, manipulate and control catheter technologies.

Issuer:Hansen Medical, Inc.
Issue:Term loan
Amount:$30 million
Coupon:9.45%
Warrants:For 660,793 shares
Warrant expiration:Seven years
Warrant strike price:$2.27
Agent:Oxford Finance LLC
Investor:Oxford Finance LLC (for $20 million) and Silicon Valley Bank (for $10 million)
Pricing date:Dec. 8
Settlement date:Dec. 9
Stock symbol:Nasdaq: HNSN
Stock price:$2.27 at close Dec. 8
Market capitalization:$130.71 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.